A Study of Olanzapine After Intranasal and Intramuscular Administration
Clinical trial NCT06600477 · COMPLETED
Trial details
- NCT number
- NCT06600477
- Sponsor
- Neurelis, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2023-11-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.